U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 2835

1.
Family cascade screening for equitable identification of familial hypercholesterolemia: study protocol for a hybrid effectiveness-implementation type III randomized controlled trial
Christina Johnson, Jinbo Chen, Mary P. McGowan, Eric Tricou, Mary Card, Amy R. Pettit, Tamar Klaiman, Daniel J. Rader, Kevin G. Volpp, Rinad S. Beidas
Implement Sci. 2024; 19: 30. Published online 2024 Apr 9. doi: 10.1186/s13012-024-01355-x
PMCID:
PMC11003060
ArticlePDF–1.1M
2.
Impact of changes in Achilles tendon thickening on cardiovascular events in patients with familial hypercholesterolemia
Hayato Tada, Nobuko Kojima, Yasuaki Takeji, Atsushi Nohara, Masa-aki Kawashiri, Masayuki Takamura
Am J Prev Cardiol. 2024 Jun; 18: 100660. Published online 2024 Mar 24. doi: 10.1016/j.ajpc.2024.100660
PMCID:
PMC10999807
ArticlePDF–1.8M
3.
Profiling of differentially expressed MicroRNAs in familial hypercholesterolemia via direct hybridization
Erika Cione, Maryam Mahjoubin-Tehran, Tiziana Bacchetti, Maciej Banach, Gianna Ferretti, Amirhossein Sahebkar
Noncoding RNA Res. 2024 Sep; 9(3): 796–810. Published online 2024 Mar 8. doi: 10.1016/j.ncrna.2024.02.017
PMCID:
PMC10999490
ArticlePDF–12M
4.
Awareness of Hypertension, Hypercholesterolemia, and Diabetes Mellitus and Associated Characteristics in Russian Adults
Filip Sahatqija, Monica Hunsberger, Sarah Cook, Kamila Kholmatova, Marina Shapkina, Sofia Malyutina, Alexander V. Kudryavtsev
Int J Hypertens. 2024; 2024: 8542671. Published online 2024 Mar 25. doi: 10.1155/2024/8542671
PMCID:
PMC10985646
ArticlePDF–416K
5.
Adverse Cardiac Events of Hypercholesterolemia Are Enhanced by Sitagliptin Administration in Sprague Dawley Rats
Henry A. Palfrey, Avinash Kumar, Rashmi Pathak, Kirsten P. Stone, Thomas W. Gettys, Subramanyam N. Murthy
Version 1. Res Sq. Preprint. 2024 Mar 19. doi: 10.21203/rs.3.rs-4075353/v1
PMCID:
PMC10984018
ArticlePDF–5.1M
6.
The design and rationale of the Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia (ACCURATE) study
Junran J. Peng, Navid Saleh, Thomas M. Roston, Adam Kramer, Lubomira Cermakova, G.B. John Mancini, Christopher B. Fordyce, Liam R. Brunham
Am Heart J Plus. 2022 Jan; 13: 100097. Published online 2022 Feb 4. doi: 10.1016/j.ahjo.2022.100097
PMCID:
PMC10978219
ArticlePDF–865K
7.
Retracted: A Systematic Review and Meta-Analysis of Therapeutic Efficacy and Safety of Alirocumab and Evolocumab on Familial Hypercholesterolemia
BioMed Research International
Biomed Res Int. 2024; 2024: 9865038. Published online 2024 Mar 20. doi: 10.1155/2024/9865038
Retracts:
Biomed Res Int. 2021; 2021: 8032978.
PMCID:
PMC10977109
RetractionPDF–514K
8.
Early Atherosclerosis in Familial Hypercholesterolemia Patients: Significance of Vascular Markers for Risk Stratification
Urte Aliosaitiene, Zaneta Petrulioniene, Egidija Rinkuniene, Antanas Mainelis, Jurate Barysiene, Urte Smailyte, Vaida Sileikiene, Aleksandras Laucevicius
J Cardiovasc Dev Dis. 2024 Mar; 11(3): 91. Published online 2024 Mar 13. doi: 10.3390/jcdd11030091
PMCID:
PMC10971247
ArticlePDF–1.1M
9.
The Health History of First-Degree Relatives’ Dyslipidemia Can Affect Preferences and Intentions following the Return of Genomic Results for Monogenic Familial Hypercholesterolemia
Tomoharu Tokutomi, Akiko Yoshida, Akimune Fukushima, Kayono Yamamoto, Yasushi Ishigaki, Hiroshi Kawame, Nobuo Fuse, Fuji Nagami, Yoichi Suzuki, Mika Sakurai-Yageta, Akira Uruno, Kichiya Suzuki, Kozo Tanno, Hideki Ohmomo, Atsushi Shimizu, Masayuki Yamamoto, Makoto Sasaki
Genes (Basel) 2024 Mar; 15(3): 384. Published online 2024 Mar 21. doi: 10.3390/genes15030384
PMCID:
PMC10970353
ArticlePDF–515K
10.
Genetic Counseling and Genetic Testing for Familial Hypercholesterolemia
Hayato Tada, Masa-aki Kawashiri, Atsushi Nohara, Tomoko Sekiya, Atsushi Watanabe, Masayuki Takamura
Genes (Basel) 2024 Mar; 15(3): 297. Published online 2024 Feb 26. doi: 10.3390/genes15030297
PMCID:
PMC10970256
ArticlePDF–1.8M
11.
Low Density Lipoprotein Cholesterol Decreases the Expression of Adenosine A2A Receptor and Lipid Rafts-Protein Flotillin-1: Insights on Cardiovascular Risk of Hypercholesterolemia
Marie-Charlotte Chaptal, Marie Maraninchi, Giorgia Musto, Julien Mancini, Hedi Chtioui, Janine Dupont-Roussel, Marion Marlinge, Julien Fromonot, Nathalie Lalevee, Florian Mourre, Sophie Beliard, Régis Guieu, René Valero, Giovanna Mottola
Cells. 2024 Mar; 13(6): 488. Published online 2024 Mar 11. doi: 10.3390/cells13060488
PMCID:
PMC10969546
ArticlePDF–1.7M
12.
Assessment of hypercholesterolemia prevalence and its demographic variations in the Republic of Kazakhstan
Mukhtar Kulimbet, Kairat Davletov, Timur Saliev, Dimash Davletov, Berik Dzhumabekov, Bauyrzhan Umbayev, Aigerim Balabayeva, Shynar Tanabayeva, Ildar Fakhradiyev
Sci Rep. 2024; 14: 7182. Published online 2024 Mar 26. doi: 10.1038/s41598-024-57884-4
PMCID:
PMC10966034
ArticlePDF–937K
13.
Identification of a novel LDLR p.Glu179Met variant in Thai families with familial hypercholesterolemia and response to treatment with PCSK9 inhibitor
Burabha Pussadhamma, Chaiyasith Wongvipaporn, Atthakorn Wutthimanop, Manit Nuinoon, Sureerut Porntadavity, Nutjaree Jeenduang
Sci Rep. 2024; 14: 6785. Published online 2024 Mar 21. doi: 10.1038/s41598-024-57069-z
PMCID:
PMC10957951
ArticlePDF–2.3M
14.
LDLR c.415G > A causes familial hypercholesterolemia by weakening LDLR binding to LDL
Kaihan Wang, Tingting Hu, Mengmeng Tai, Yan Shen, Haocheng Chai, Shaoyi Lin, Xiaomin Chen
Lipids Health Dis. 2024; 23: 85. Published online 2024 Mar 21. doi: 10.1186/s12944-024-02068-2
PMCID:
PMC10956282
ArticlePDF–1.8M
15.
CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing
Sijia Xu, Hiroki Shiomi, Yugo Yamashita, Satoshi Koyama, Takahiro Horie, Osamu Baba, Masahiro Kimura, Yasuhiro Nakashima, Naoya Sowa, Koji Hasegawa, Ayako Suzuki, Yutaka Suzuki, Takeshi Kimura, Koh Ono
PLoS One. 2024; 19(3): e0297231. Published online 2024 Mar 20. doi: 10.1371/journal.pone.0297231
PMCID:
PMC10954175
ArticlePDF–2.1M
16.
Effect of clinical decision support for severe hypercholesterolemia on low-density lipoprotein cholesterol levels
Hana Bangash, Seyedmohammad Saadatagah, Mohammadreza Naderian, Marwan E. Hamed, Lubna Alhalabi, Alborz Sherafati, Joseph Sutton, Omar Elsekaily, Ali Mir, Justin H. Gundelach, Daniel Gibbons, Paul Johnsen, Christina M. Wood-Wentz, Carin Y. Smith, Pedro J. Caraballo, Kent R. Bailey, Iftikhar J. Kullo
NPJ Digit Med. 2024; 7: 73. Published online 2024 Mar 18. doi: 10.1038/s41746-024-01069-w
PMCID:
PMC10948900
ArticlePDF–735K
17.
Primär- und Sekundärprävention bei Hypercholesterinämie – versorgungsrelevante Unterschiede in der PROCYON-Studie
Umidakhon Makhmudova, Michaela Wolf, Kathy Willfeld, Lea Beier, Oliver Weingärtner
Dtsch Med Wochenschr. 2023 Sep; 148(19): e101–e110. German. Published online 2023 Aug 21. doi: 10.1055/a-2117-6504
PMCID:
PMC10946085
ArticlePDF–672K
18.
Failure of lipid control by PCSK9 inhibitors in compound heterozygous familial hypercholesterolemia complicated with premature myocardial infarction: A case report
Ziyue Zhang, Rongpei Yang, Jun Zhu, XiaoLi Yang, Hao Luo, Hongyong Wang, Xiaoli Luo
Clin Case Rep. 2024 Mar; 12(3): e8498. Published online 2024 Mar 14. doi: 10.1002/ccr3.8498
PMCID:
PMC10939999
ArticlePDF–855K
19.
Development and utility of a clinical research informatics application for participant recruitment and workflow management for a return of results pilot trial in familial hypercholesterolemia in the Million Veteran Program
Charles A Brunette, Thomas Yi, Morgan E Danowski, Mark Cardellino, Alicia Harrison, Themistocles L Assimes, Joshua W Knowles, Kurt D Christensen, Amy C Sturm, Yan V Sun, Qin Hui, Saiju Pyarajan, Yunling Shi, Stacey B Whitbourne, J Michael Gaziano, Sumitra Muralidhar, Jason L Vassy
JAMIA Open. 2024 Apr; 7(1): ooae020. Published online 2024 Mar 8. doi: 10.1093/jamiaopen/ooae020
PMCID:
PMC10923213
ArticlePDF–1.1M
20.
Long-term Efficacy and Safety of K-924 Pitavastatin/Ezetimibe Fixed-dose Combination in Patients with Hypercholesterolemia: A Phase III, Multi-center, Open-label Trial
Junya Ako, Koutaro Yokote, Kenichi Tsujita, Ryohei Tanigawa, Ryo Kamei, Hideki Suganami
J Atheroscler Thromb. 2024 Mar 1; 31(3): 288–305. Published online 2023 Sep 16. doi: 10.5551/jat.64272
PMCID:
PMC10918028
ArticlePDF–291K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center